CAS: 13002-65-8 - trans-2-(4-(1,2-diphenyl-1-butenyl)-phenoxy)-N,N-
Fórmula:C28H32
InChI:InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25+
Chave InChI:InChIKey=NKANXQFJJICGDU-OCEACIFDSA-N
SMILES:O(C1=CC=C(C=C1)C(C=2C=CC=CC2)=C(C=3C=CC=CC3)CC)CCN(C)C
- Sinónimos:
- (E)-Tamoxifen
- 2-[4-[(1E)-1,2-Diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethylethanamine
- Brn 2062021
- Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (E)-
- Ethanamine, 2-[4-[(1E)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-
- Ethanamine, 2-[4-[(1E)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-
- Ethylamine, 2-[p-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (E)-
- Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (E)-
- Tamoxifen (E)
- cis-Tamoxifen
- Ver mais sinónimos
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Tamoxifen Citrate EP Impurity A ((E)-Tamoxifen) REF: 4Z-T-0110CAS: 13002-65-8 | - - - | A consultar | Seg 16 Dez 24 | |
(E)-Tamoxifen REF: TR-T006010CAS: 13002-65-8 | - - - | 494,00 €~1.391,00 € | Sex 27 Dez 24 | |
(E)-Tamoxifen REF: 3D-FT27995CAS: 13002-65-8 | Min. 98 Area-% | 387,00 €~1.852,00 € | Sex 27 Dez 24 | |
(E)-Tamoxifen-13C2, 15N REF: TR-T006012CAS: 13002-65-8 | - - - | 17.785,00 € | Seg 27 Jan 25 | |
(E/Z)-Tamoxifen REF: TR-T006005CAS: | - - - | - - - | Produto descontinuado |
Tamoxifen Citrate EP Impurity A ((E)-Tamoxifen)
Ref: 4Z-T-0110
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Ref: TR-T006010
5mg | 832,00 € | ||
10mg | 1.391,00 € | ||
2500µg | 494,00 € |
(E)-Tamoxifen
Produto ControladoRef: 3D-FT27995
1mg | 517,00 € | ||
2mg | 738,00 € | ||
5mg | 1.235,00 € | ||
10mg | 1.852,00 € | ||
500µg | 387,00 € |
(E)-Tamoxifen-13C2, 15N
Produto ControladoRef: TR-T006012
50mg | 17.785,00 € |
(E/Z)-Tamoxifen
Ref: TR-T006005
10mg | Descontinuado | Solicitar informações | |
100mg | Descontinuado | Solicitar informações |